Abivax SA Appoints Chris Rabbat as Chief Marketing Officer and Tim Kelly as Chief Technology Officer
Position
Chief Technology Officer
Company
Abivax
New YorkBiotechnologyHealth CareMedicalTherapeuticsPharmaceuticalConsultingLegalBiopharmaDescription
Abivax SA has announced the appointments of Chris Rabbat as Chief Marketing Officer and Tim Kelly as Chief Technology Officer. This leadership change comes as the company prepares for the potential commercialization of its lead product, obefazimod. The transition is expected to strengthen their capabilities in regulatory and launch execution.
Quick answer
Abivax SA Appoints Chris Rabbat as Chief Marketing Officer and Tim Kelly as Chief Technology Officer (September 21, 2026). Abivax is based in New York, United States.
- Who is the new Chief Technology Officer at Abivax?
- Abivax named Tim Kelly Chief Technology Officer, announced September 21, 2026.
- What did Abivax announce on September 21, 2026?
- Abivax SA has announced the appointments of Chris Rabbat as Chief Marketing Officer and Tim Kelly as Chief Technology Officer. This leadership change comes as the company prepares for the potential commercialization of its lead product, obefazimod.
- What does Abivax do?
- Abivax is developing therapies that modulate the body’s natural immune system machinery.
- Where is Abivax based?
- Abivax is based in New York, United States.
- Which similar companies made leadership changes around the same time?
- Aquestive Therapeutics, Inc. (September 29, 2026), Os Therapies (October 1, 2026), Retension Pharmaceuticals (September 10, 2026) and Jazz Pharmaceuticals plc (October 9, 2026) also announced leadership changes within 45 days of Abivax.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Richard J. Daly Appointed as Director of Aquestive Therapeutics (September 29, 2026)
- OS Therapies Appoints Mr. Clem as Chief Commercial Officer and Mr. Knuettel as Chief Financial Officer (October 1, 2026)
- Retension Pharmaceuticals Appoints LeAnne Bloedon as EVP of Clinical Development (September 10, 2026)
- Jazz Pharmaceuticals Announces Transition in Leadership (October 9, 2026)
- Arletta Pharma Solutions Appoints Jeannette Jager-van Dijk as Chief Executive Officer (September 1, 2026)
- Harmony Biosciences Appoints Peter Anastasiou as Chief Executive Officer (October 12, 2026)
Who to call at Abivax, and when
A new leader at Abivax brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Abivax raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Abivax, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Abivax. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Abivax changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Abivax changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.